Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Abbott Laboratories (ABT)

Abbott Laboratories (ABT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 159,868,432
  • Shares Outstanding, K 1,768,456
  • Annual Sales, $ 30,578 M
  • Annual Income, $ 2,368 M
  • 60-Month Beta 1.12
  • Price/Sales 5.03
  • Price/Cash Flow 18.88
  • Price/Book 5.01

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate 0.70
  • Number of Estimates 6
  • High Estimate 0.71
  • Low Estimate 0.70
  • Prior Year 0.63
  • Growth Rate Est. (year over year) +11.11%

Price Performance

See More
Period Period Low Period High Performance
1-Month
84.01 +6.64%
on 01/14/20
92.45 -3.09%
on 01/22/20
+2.19 (+2.51%)
since 12/27/19
3-Month
80.90 +10.74%
on 11/05/19
92.45 -3.09%
on 01/22/20
+7.94 (+9.72%)
since 10/25/19
52-Week
68.80 +30.22%
on 01/29/19
92.45 -3.09%
on 01/22/20
+18.44 (+25.92%)
since 01/25/19

Most Recent Stories

More News
Abbott Receives Expanded Indication From the U.S. FDA for Directional Deep Brain Stimulation System to Treat Parkinson's Disease

Abbott (NYSE: ABT) today announced it received approval from the U.S. Food and Drug Administration (FDA) for a new, expanded indication for the company's Infinity(TM) Deep Brain Stimulation (DBS) system...

ABT : 89.59 (-0.90%)
Global Epilepsy Therapeutics Market 2020 – Abbott Laboratories , GlaxoSmithKline plc , Cephalon , Johnson & Johnson , Pfizer

ABT : 89.59 (-0.90%)
GSK : 46.48 (-1.59%)
NVS : 93.70 (-0.18%)
VRX.TO : 30.80 (-3.33%)
Point Of Care Test Market 2019 Industry Trends, Opportunities and Forecast 2025

(MENAFN - Ameliorate Solutions) The Global Point Of Care Test Market Research Report Forecast 2019-2025: The research study has been prepared with the use of in-depth qualitative and quantitative analyses...

ABAX : 83.00 (-0.11%)
ABT : 89.59 (-0.90%)
Point Of Care Test Market 2019 Industry Trends, Opportunities and Forecast 2025

: The research study has been prepared with the use of in-depth qualitative and quantitative analyses of the global Point Of Care Test Market. The report offers complete and intelligent analysis of the...

ABAX : 83.00 (-0.11%)
ABT : 89.59 (-0.90%)
New Quality of Life and Functional Improvement Data From Abbott's BOLD and TRIUMPH Studies Reinforce Benefit of Proclaim(TM) XR Neurostimulation System In People Living with Chronic Pain

Abbott (NYSE: ABT) announced positive results from a prospective, multicenter study, providing the scientific basis for the company's Proclaim(TM) XR recharge-free neurostimulation system for people living...

ABT : 89.59 (-0.90%)
Best Relative Performance in the Health Care Equipment Industry Detected in Shares of Abbott Labs (ABT , DXCM , ISRG , ZBH , VAR )

Below are the top five companies in the Health Care Equipment industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that...

ABT : 89.59 (-0.90%)
DXCM : 235.45 (+0.65%)
ISRG : 567.50 (-3.68%)
Asian shares higher despite growing impact of China virus

BANGKOK (AP) — Asian shares were mostly higher Thursday as health authorities around the world moved to monitor and contain a deadly virus outbreak in China and keep it from spreading globally.

BAC : 32.85 (-2.06%)
JPM : 132.03 (-0.84%)
ABT : 89.59 (-0.90%)
T : 38.25 (-0.65%)
NFLX : 342.88 (-2.91%)
IBM : 138.62 (-1.38%)
COF : 101.16 (-3.01%)
TSLA : 558.02 (-1.20%)
Watch for Abbott Labs to Potentially Pullback After Gaining 2.51% Yesterday

Abbott Labs (NYSE:ABT) traded in a range yesterday that spanned from a low of $90.03 to a high of $92.45. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $89.34...

ABT : 89.59 (-0.90%)
Breaking Q4 Earnings News

Breaking Q4 Earnings News

FITB : 28.50 (-1.18%)
JNJ : 148.75 (+0.29%)
ABT : 89.59 (-0.90%)
Chicago Econ Numbers & More Q4 Earnings: JNJ, ABT, FITB

Certain weeks of the year are rife with important information for the stock market. This is not one of those weeks.

FITB : 28.50 (-1.18%)
JNJ : 148.75 (+0.29%)
ABT : 89.59 (-0.90%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade ABT with:

Business Summary

Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.

See More

Key Turning Points

2nd Resistance Point 90.60
1st Resistance Point 90.09
Last Price 89.59
1st Support Level 88.99
2nd Support Level 88.39

See More

52-Week High 92.45
Last Price 89.59
Fibonacci 61.8% 83.42
Fibonacci 50% 80.63
Fibonacci 38.2% 77.83
52-Week Low 68.80

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar